(NASDAQ: RDNT) Radnet's forecast annual revenue growth rate of 7.78% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.67%.
Radnet's revenue in 2025 is $1,969,599,000.On average, 10 Wall Street analysts forecast RDNT's revenue for 2025 to be $157,764,269,390, with the lowest RDNT revenue forecast at $150,512,513,242, and the highest RDNT revenue forecast at $163,318,806,014. On average, 10 Wall Street analysts forecast RDNT's revenue for 2026 to be $174,736,464,630, with the lowest RDNT revenue forecast at $157,764,269,390, and the highest RDNT revenue forecast at $185,382,659,826.
In 2027, RDNT is forecast to generate $189,780,001,320 in revenue, with the lowest revenue forecast at $165,710,342,616 and the highest revenue forecast at $204,283,513,616.